Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis

NCT02066623 is registered in ClinicalTrials.gov with IHF GmbH - Institut für Herzinfarktforschung as lead sponsor.

NCT NCT02066623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02066623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Lead sponsor
IHF GmbH - Institut für Herzinfarktforschung
Phase
Observational
Overall status
Completed
Start date
November 8, 2013
Completion date
July 6, 2021
Enrollment
3,330 (actual)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery stenosis